ELUT FY 2019 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$47M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43M+9.9% YoY

Gross Profit

$20M46.1% margin

Operating Income

-$8M-19.6% margin

Net Income

-$12M-27.8% margin

EPS (Diluted)

$-1.12

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$208,000

Balance Sheet

Total Assets

$45M

Total Liabilities

$100M

Stockholders' Equity

-$55M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$39M	+9.9%
Gross Profit	$20M	$16M	+24.0%
Operating Income	-$8M	-$8M	-2.3%
Net Income	-$12M	-$12M	-3.2%